Regis Technologies is an Illinois-based CDMO that provides discovery, lead molecule development, and drug commercialization support to the pharmaceutical and biotechnology industries. Regis provides end-to-end GMP API manufacturing, including IND-enabling supply, clinical trial material, commercial API, and specialized orphan drug and fast-track services. In addition to robust API development and manufacturing, the company provides CMC, micronization, and HPAPI manufacturing services.